Author

S. van Veen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Kourti· 1 shared C. Carvalho dos Santos· 1 shared C. G. Engele· 1 shared C. J. Korbee· 1 shared C. Van den Haute· 1 shared E. Ausloos· 1 shared F. A. Verreck· 1 shared F. Vrieling· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Kourti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ATP13A4 upregulation drives the elevated polyamine transport system in the breast cancer cell line MCF7

S. van Veen, A. Kourti, E. Ausloos, J. Van Asselberghs, C. Van den Haute, V. Baekelandt, J. Eggermont, P. Vangheluwe

This study identifies ATP13A4 as a key polyamine transporter upregulated in breast cancer cells, contributing to increased polyamine uptake and sensitivity to polyamine toxicity.

bioRxiv · Mar 31, 2023 · PreprintCell Biology

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

M. T. Heemskerk, C. J. Korbee, J. Esselink, C. Carvalho dos Santos, S. van Veen, I. F. Gordijn, F. Vrieling, K. V. Walburg, C. G. Engele, K. Dijkman, L. Wilson, F. A. Verreck, M. C. Haks, T. H. Ottenhoff

This study identifies two antipsychotic drugs, Pimozide and Fluspirilene, as potential host-directed therapies for Mycobacterium tuberculosis and Salmonella enterica infections by modulating autophagy and lysosomal responses.

bioRxiv · Jun 5, 2021Immunology